Chipscreen
68832127.190.04% ( +0.01 )
Chipscreen (688321)
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the pharmaceutical industry in China. The company develops Chidamide, a subtype-selective histone deacetyla...
- Open
- 27.38
- High
- 27.50
- Low
- 26.40
- Prev. Close
- 27.18
- Volume
- 65.14K
- Turnover
- 176.39M
- Avg Price
- 27.08
- Bid/Ask Ratio
- --
- Amplitude
- 4.05%
- 52wk High
- 44.93
- Volume Ratio
- 0.70
- Turnover Ratio
- 1.60%
Chipscreen Analyst Rating
View MoreForecast & Rating
Dec 2, 2024Price forecast
¥37.6038.24%
Forecast & RatingStrong buy
1analysts
- Strong buy100.00%
- Buy0.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- CoinLive · Jun 27 at 03:00 AM
Lead Intelligent, SGMICRO, and ChipScreen List on HKEX Main Board in A+H Wave
- Wallstreetcn · Jan 29 at 07:30 PM
The China Securities Convertible Bond Index opened down 0.15%, reporting 528.92 points. Jin 25 Convertible Bond, Newtouch Convertible Bond, Zhenhua Convertible Bond, Chipscreen Convertible Bond, and Thalys Convertible Bond had the largest declines, falling by 5.24%, 4.04%, 3.02%, 2.74%, and 2.48%, respectively. NAIPU MINING Convertible Bond 02, Novoray Convertible Bond, HAOMEI Convertible Bond, TOPSCORE FASHION Convertible Bond, and Huakang Clean Convertible Bond had the largest increases, rising by 30.00%, 8.96%, 3.27%, 2.97%, and 1.74%, respectively
- prnewswire · Dec 29, 2025 at 06:46 PM
19:45 ET Dr. Lu Xianping, Founder, Chairman of Chipscreen Biosciences named the Chinese mainland winner of the EY Entrepreneur Of The Year™ 2025 awards
- Zhitong · Oct 31, 2025 at 05:01 AM
Chipscreen plans to repurchase shares for 10 million to 15 million yuan
- Zhitong · Oct 30, 2025 at 05:48 AM
Chipscreen: The net profit for the third quarter is 41.1753 million yuan
- Zhitong · Sep 10, 2025 at 06:29 AM
Chipscreen: Bio-Thera Solutions plans to reduce its holdings by no more than 3% of shares
